Search Results - "Elias, Keren"

Quantitation of Aurora Kinase A Gene Copy Number in Urine Sediments and Bladder Cancer Detection by Park, Hong-Seok, Park, Weon Seo, Bondaruk, Jolanta, Tanaka, Noriyoshi, Katayama, Hiroshi, Lee, Sangkyou, Spiess, Philippe E., Steinberg, Jordan R., Wang, Zhi, Katz, Ruth L., Dinney, Colin, Elias, Keren J., Lotan, Yair, Naeem, Rizwan C., Baggerly, Keith, Sen, Subrata, Grossman, H. Barton, Czerniak, Bogdan

“…Background Chromosome missegregation and the resulting aneuploidy is a common change in neoplasia. The Aurora kinase A (AURKA) gene, which encodes a key…”
Get full text

Methylation Profiles of Sporadic Ovarian Tumors and nonmalignant Ovaries from High-Risk Women by RATHI, Asha, VIRMANI, Arvind K, SCHORGE, John O, ELIAS, Keren J, MARUYAMA, Riichiroh, MINNA, John D, MOK, Samuel C, GIRARD, Luc, FISHMAN, David A, GAZDAR, Adi F

“…Purpose: The purpose of this research was to examine the DNA methylation profiles of primary sporadic ovarian cancers and ovarian tissues from high-risk women…”
Get full text

P16 as a molecular biomarker of cervical adenocarcinoma by Schorge, John O, Lea, Jayanthi S, Elias, Keren J, Rajanbabu, Ramababu, Coleman, Robert L, Miller, David S, Ashfaq, Raheela

“…Cervical adenocarcinomas are increasing in incidence each year. The aim of this study was to identify a molecular biomarker to improve early detection…”
Get full text

Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation by Terrell, John D, Elias, Keren J, Sagalowsky, Arthur I, Lotan, Yair

“…Urine based tumor markers have uncertain utility in diagnosis or surveillance of patients with bladder cancer while cytology is commonly used. We evaluated…”
Get full text

High‐risk patients with hematuria are not evaluated according to guideline recommendations by Elias, Keren, Svatek, Robert S., Gupta, Samir, Ho, Richard, Lotan, Yair

“…BACKGROUND: To determine whether high‐risk patients with hematuria receive evaluation according to guideline recommendations. METHODS: We recently performed a…”
Get full text

Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker by Lotan, Yair, Elias, Keren, Svatek, Robert S, Bagrodia, Aditya, Nuss, Geoffrey, Moran, Brett, Sagalowsky, Arthur I

“…We evaluated whether screening high risk asymptomatic individuals with a bladder tumor marker can lead to earlier detection and resultant down staging of…”
Get more information